We have previously reported that in acute respiratory distress syndrome (AR
DS), nonsurvivors have persistent elevation in pulmonary and circulating pr
oinflammatory cytokine levels over time and a high rate of nosocomial infec
tions antemortem. In these patients, none of the proven or suspected nosoco
mial infections caused a transient or sustained increase in plasma proinfla
mmatory cytokine levels above preinfection values. We hypothesized that cyt
okines secreted by the host during ARDS may favor the growth of bacteria. W
e conducted an in vitro study of the growth of three bacteria clinically re
levant in nosocomial infections, evaluating their in vitro response to vari
ous concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1
beta, and IL-6. We found that all three bacterial species showed concentra
tion-dependent growth enhancement when incubated with one or more tested cy
tokines and that blockade by specific neutralizing cytokine MoAb significan
tly inhibited cytokine-induced growth. When compared with control, the 6-h
growth response (cfu/ml) was maximal with II-1 beta at 1,000 pg for Staphyl
ococcus aureus (36 +/- 16 versus 377 +/- 16; p = 0.0001) and Acinetobacter
spp. (317 +/- 1,147 versus 1,124 +/- 147; p = 0.002) and with IL-6 at 1,000
pg for Pseudomonas aeruginosa (99 +/- 50 versus 509 +/- 50; p = 0.009). Th
e effects of cytokines were seen only with fresh isolates and were lost wit
h passage in vitro on bacteriologic medium without added cytokines. In this
study we provide additional evidence for a newly described pathogenetic me
chanism for bacterial proliferation in the presence of exaggerated and prot
racted inflammation.